Status:
COMPLETED
Measuring the ACT During Non-cardiac Arterial Procedures.
Lead Sponsor:
Dijklander Ziekenhuis
Collaborating Sponsors:
Medtronic
Conditions:
Arterial Disease
Surgery
Eligibility:
All Genders
18+ years
Brief Summary
Aim of the MANCO study is to establish for once and for all that monitoring the effect of heparin during NCVI (Non-Cardiac Vascular Interventions) is essential to ensure the individual patient of safe...
Detailed Description
Heparin is used worldwide by all vascular surgeons and interventional radiologists (IR) during non-cardiac vascular interventions (NCVI), both open and endovascular. Heparin is used to reduce or preve...
Eligibility Criteria
Inclusion
- All patients in participating centers undergoing Non-Cardiac Vascular (arterial) Intervention open or endovascular, older than 18 years
Exclusion
- Patients with a known history of coagulation disorders or a EGFR lower than 30 ml/min.
Key Trial Info
Start Date :
December 21 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2024
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03426293
Start Date
December 21 2016
End Date
January 31 2024
Last Update
February 6 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Vrije Universiteit Medisch Centrum
Amsterdam, North Holland, Netherlands, 1081HV
2
Westfriesgasthuis
Hoorn, North Holland, Netherlands, 1624NP
3
Isala klinieken
Zwolle, Netherlands, 8025 AB